Literature DB >> 8614769

Acute sarcoid arthritis: a favourable outcome? A retrospective survey of 49 patients with review of the literature.

J T Gran1, E Bøhmer.   

Abstract

Forty-nine patients, 30 males and 19 females with acute sarcoid arthritis admitted to three different hospitals in Norway were studied retrospectively. All patients had peripheral arthritis and hilar adenopathy, and 87.8% also presented with erythema nodosum (EN). Mean duration of arthritis was 3.7 months (0.5-12 months), but in 26% of the cases, duration of the inflammatory joint disease exceeded three months. Radiological bony erosions were not seen. Two patients had recurrence of acute sarcoid arthritis, 14 months and 10 years after the initial episode, respectively. Two other patients developed chronic myalgia and fibromyalgia. Four patients, one female and three males, developed chronic pulmonal sarcoidosis. Of these, two patients had simultaneous onset of acute sarcoid arthritis and parenchymal disease while two patients developed chronic lung disease three months after onset of acute sarcoid arthritis. We thus tentatively suggest that although acute sarcoid arthritis is usually a self-limiting joint disease, recurrences may occasionally occur and some cases develop chronic sarcoidosis of the lungs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614769     DOI: 10.3109/03009749609069210

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  14 in total

Review 1.  Radiologic Manifestations of Musculoskeletal Sarcoidosis.

Authors:  Júlio Brandão Guimarães; Marcelo A Nico; Alípio G Omond; Flávio D Silva; Laís Uyeda Aivazoglou; Bruno C Carneiro; Artur R C Fernandes
Journal:  Curr Rheumatol Rep       Date:  2019-02-14       Impact factor: 4.592

Review 2.  [Musculoskeletal manifestations of sarcoidosis].

Authors:  P Korsten; G Chehab
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

3.  Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.

Authors:  H Visser; K Vos; E Zanelli; W Verduyn; G M Th Schreuder; I Speyer; F C Breedveld; J M W Hazes
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

4.  Refractory sarcoid arthritis in World Trade Center-exposed New York City firefighters: a case series.

Authors:  Konstantinos Loupasakis; Jessica Berman; Nadia Jaber; Rachel Zeig-Owens; Mayris P Webber; Michelle S Glaser; William Moir; Basit Qayyum; Michael D Weiden; Anna Nolan; Thomas K Aldrich; Kerry J Kelly; David J Prezant
Journal:  J Clin Rheumatol       Date:  2015-01       Impact factor: 3.517

5.  The clinical characteristics of sarcoid arthropathy based on a prospective cohort study.

Authors:  Senol Kobak; Fidan Sever; Ozan Usluer; Tuncay Goksel; Mehmet Orman
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-09-23       Impact factor: 5.346

Review 6.  Rheumatologic manifestations of sarcoidosis.

Authors:  Nadera J Sweiss; Karen Patterson; Ray Sawaqed; Umair Jabbar; Peter Korsten; Kyle Hogarth; Robert Wollman; Joe G N Garcia; Timothy B Niewold; Robert P Baughman
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

7.  Lofgren's Syndrome-Acute Onset Sarcoidosis and Polyarthralgia: A Case Report.

Authors:  Chan Woo Byun; Seung Nam Yang; Joon Shik Yoon; Se Hwa Kim
Journal:  Ann Rehabil Med       Date:  2013-04-30

Review 8.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

9.  Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-05       Impact factor: 4.794

Review 10.  Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis.

Authors:  Ulrike Seitzer; Johannes Gerdes; Joachim Müller-Quernheim
Journal:  Respir Res       Date:  2001-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.